Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262195 · ClinicalTrials.gov registry record
Dysfunctional Hemoglobin
A clinical trial of Elevated Levels of Carboxyhemoglobin and Methemoglobin, sponsored by Nonin Medical.
- Completed
- Registry status
- 62
- Enrollment target
- 1
- Study location
NCT02262195: Completed study of Elevated Levels of Carboxyhemoglobin and Methemoglobin, sponsored by Nonin Medical.
NCT02262195 is a study of Elevated Levels of Carboxyhemoglobin and Methemoglobin that has completed, run by Nonin Medical. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02262195, a study of Elevated Levels of Carboxyhemoglobin and Methemoglobin, has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.
Conditions Studied
Interventions
- OTHER Elevated levels of carboxyhemoglobin
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02262195
The ClinicalTrials.gov registry entry for NCT02262195 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nonin Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Elevated Levels of Carboxyhemoglobin and Methemoglobin appearing as the primary indexed condition, and to 1 intervention - of which Elevated levels of carboxyhemoglobin is the first listed.
NCT02262195 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02262195 about?
NCT02262195 is a clinical study titled "Dysfunctional Hemoglobin". The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.
What is the current status of trial NCT02262195?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2014-10. Estimated completion is 2015-03.
What conditions does trial NCT02262195 study?
This clinical trial studies the following conditions: Elevated Levels of Carboxyhemoglobin and Methemoglobin.
What interventions are being tested in trial NCT02262195?
The interventions under investigation include: Elevated levels of carboxyhemoglobin (OTHER).
Who is sponsoring clinical trial NCT02262195?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02262195 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.